Alfred L. Garfall, MD, opens a discussion underscoring the unmet needs in multiple myeloma.
ASCO 2024: Updates in Multiple Myeloma
Dr Garfall, MD, provides insights following results derived from the MajesTEC-1 study.
Dr Garfall, MD, provides further insights around the MajesTEC-1 study.
Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
3
Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups
4
SGLT2 Inhibitors Tied to Lower Platelet Activation in HFrEF
5